JN-304

N/A

Report date: 2024/12/16 16:26:38

Base Information

Drug NameJN-304
Drug Alias NameKB-304JN-304
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vector > HSV-1 vector
Mechanisms of ActionCollagen replacementsExtracellular matrix protein replacementGene transference
TargetsExtracellular matrix protein
Therapy Area/IndicationsNasolabial fold wrinklesSkin AgingPigmentation Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJeune Inc
China Registration ClassN/A

Develop Information

Active CompaniesJeune IncKrystal Biotech Inc
Inactive CompaniesN/A
Active IndicationsNasolabial fold wrinklesSkin AgingPigmentation Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A